A novel immunomodulatory peptide that can be used for treatment of infectious diseases, Cardiovascular Ischemia/Reperfusion injury, Acute Kidney Injury and Multiple Myeloma

Technology request: A novel immunomodulatory peptide that can be used for treatment of infectious diseases, Cardiovascular Ischemia/Reperfusion injury, Acute Kidney Injury and Multiple Myeloma

Reference: 12 IL 80EP 3O1C

Summary: An Israeli clinical stage biotechnology company is looking for a partner to collaborate on developing its lead compound, a short peptide antagonist of CD28, for treatment of immune related diseases. The company is seeking to collaborate with service providers, academic researchers and clinical investigators in the fields of drug development (preclinical and clinical) in the area of Cardiovascular Ischemia reperfusion injury and multiple myeloma.

For more information click here.

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.